Now showing items 1-5 of 5

    • Ansiedade e depressão na população jovem: tratamentos, eventos adversos e atuação farmacêutica 

      Gonçalves, Mayara Fernandes [UNIFESP] (Universidade Federal de São Paulo, 2019-11-27)
      A adolescência é um período vulnerável à instalação de sintomas depressivos e de ansiedade, por ser uma fase de reorganização emocional. A ansiedade é caracterizada como uma emoção ou estado de humor negativo caracterizada ...

    • Construction of a tool to measure perceptions about the use of the World Health Organization Safe Surgery Checklist Program 

      dos Santos Diego, Luis Antonio; Salman, Fabiane Cardia; Silva, Joao Henrique; Brandao, Julio Cezar [UNIFESP]; de Oliveira Filho, Getulio [UNIFESP]; Carneiro, Antonio Fernando; Bagatini, Airton; de Moraes, Jose Mariano (Elsevier Science Inc, 2016)
      Background: The World Health Organization (WHO) has recommended greater attention to patient safety, particularly regarding preventable adverse events. The Safe Surgery Saves Lives (CSSV) program was released recommending ...

    • Early life exposure to violence and substance misuse in adulthood-The first Brazilian national survey 

      Madruga, Clarice S. [UNIFESP]; Laranjeira, Ronaldo; Caetano, Raul; Ribeiro, Wagner; Zaleski, Marcos; Pinsky, Ilana; Ferri, Cleusa P. (Elsevier B.V., 2011-03-01)
      Background: Substance misuse has been a major source of health and social problems in developing societies as it has been elsewhere. There is a growing body of evidence from developed nations linking early exposure to ...

    • Stress-related telomere length in children: A systematic review 

      Coimbra, Bruno Messina [UNIFESP]; Carvalho, Carolina Muniz [UNIFESP]; Moretti, Patricia Natalia [UNIFESP]; Mello, Marcelo Feijo [UNIFESP]; Belangero, Sintia I. [UNIFESP] (Pergamon-Elsevier Science Ltd, 2017)
      Telomeres are repetitive DNA sequences at the ends of chromatids that shorten following each cell replication. Once telomeres reach a critical length, DNA defense mechanisms can direct cells to either a state of arrest ...

    • Update on Omalizumab for Urticaria: What's New in the Literature from Mechanisms to Clinic 

      Larenas-Linnemann, Desiree E. S.; Parisi, Claudio A. S.; Ritchie, Carla; Cardona-Villa, Ricardo; Cherrez-Ojeda, Ivan; Cherrez, Annia; Ensina, Luis Felipe [UNIFESP]; Garcia, Elizabeth; Medina, Iris V.; Rodriguez-Gonzalez, Mnica; Sanchez Caraballo, Jorge Mario (Current Medicine Group, 2018)
      Purpose of Review Since omalizumab has been approved for urticaria, numerous randomized and real-life observational trials have been published. We reviewed the period January 2017 February 2018. Recent Findings Omalizumab ...